Search Results - "Decristoforo, C."
-
1
2 speaker: European Regulations on Radiopharmaceuticals - A Professional’s Perspective
Published in Radiotherapy and oncology (01-03-2010)Get full text
Journal Article -
2
On-cartridge preparation and evaluation of 68Ga-, 89Zr- and 64Cu-precursors for cell radiolabelling
Published in Nuclear medicine and biology (01-04-2019)“…Indium-111 when formulated as indium-111 oxine remains the gold standard for long term cell tracking, whereas radiometals for improved PET applications still…”
Get full text
Journal Article -
3
Molecular Imaging: In Vivo Agents for the Diagnosis and Treatment of Cancer
Published in Contrast media and molecular imaging (01-01-2018)“…The topics cover the development of molecular imaging agents targeting the cholecystokinin 2 receptor (CCK2R), the adenosine A3 receptor (A3R), and the human…”
Get full text
Journal Article -
4
Radiopharmaceuticals are special, but is this recognized? The possible impact of the new Clinical Trials Regulation on the preparation of radiopharmaceuticals
Published in European journal of nuclear medicine and molecular imaging (01-11-2014)“…Nuclear medicine techniques are in the forefront of molecular imaging, thereby translating discoveries in molecular biology, genetics, pharmacology and many…”
Get full text
Journal Article -
5
Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticals
Published in EJNMMI radiopharmacy and chemistry (21-03-2016)“…This is a position paper of the Radiopharmacy Committee of the EANM (European Association of Nuclear Medicine) addressing toxicology studies for application of…”
Get full text
Journal Article -
6
Full automation of (68)Ga labelling of DOTA-peptides including cation exchange prepurification
Published in Applied radiation and isotopes (01-02-2010)“…Here we describe a fully automated approach for the synthesis of (68)Ga-labelled DOTA-peptides based on pre-concentration and purification of the generator…”
Get full text
Journal Article -
7
Towards a harmonized radiopharmaceutical regulatory framework in Europe?
Published in The quarterly journal of nuclear medicine and molecular imaging (01-08-2009)“…Despite European unification regarding a common legal framework for many aspects of pharmaceutical production including industrial manufacture of…”
Get full text
Journal Article -
8
Expression of somatostatin receptor subtype 2 and subtype 5 in thyroid malignancies
Published in Nuklearmedizin. Nuclear medicine (01-01-2014)“…To retrospectively analyse the expression of somatostatin receptor subtypes 2 (SSTR 2) and 5 (SSTR 5) in thyroid malignancies, possibly the most relevant…”
Get more information
Journal Article -
9
Evidence for Somatostatin receptor 2 in thyroid tissue
Published in Regulatory peptides (10-01-2007)“…Somatostatin receptor scintigraphy has found considerable interest for imaging thyroid tumours. Recently, also therapeutic application of Somatostatin…”
Get full text
Journal Article -
10
68Ga-DOTA-TOC uptake in neuroendocrine tumour and healthy tissue: differentiation of physiological uptake and pathological processes in PET/CT
Published in European journal of nuclear medicine and molecular imaging (01-04-2013)“…Purpose We wanted to establish the range of 68 Ga-DOTA-TOC uptake in liver and bone metastases of patients with neuroendocrine tumours (NET) and to establish…”
Get full text
Journal Article -
11
Comparison of in vitro and in vivo properties of [99mTc]cRGD peptides labeled using different novel Tc-cores
Published in The quarterly journal of nuclear medicine and molecular imaging (01-03-2007)“…The alfa(v)beta(3) integrin is involved in angiogenesis and tumor metastasis. Arginine-glycine-aspartic acid (RGD)-peptides bind with high affinity to this…”
Get full text
Journal Article -
12
Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence
Published in European journal of nuclear medicine (01-08-1999)“…In this paper the preclinical evaluation of the somatostatin analogue RC160 labelled with technetium-99m using bifunctional chelators (BFCs) based on the…”
Get full text
Journal Article -
13
The specific case of radiopharmaceuticals and GMP—activities of the Radiopharmacy Committee
Published in European journal of nuclear medicine and molecular imaging (01-07-2008)Get full text
Journal Article -
14
99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours
Published in European journal of nuclear medicine and molecular imaging (01-08-2007)“…Different attempts have been made to develop a suitable radioligand for targeting CCK-2 receptors in vivo, for staging of medullary thyroid carcinoma (MTC) and…”
Get full text
Journal Article -
15
99mTc-Labeling and in Vitro and in Vivo Evaluation of HYNIC- and (Nα-His)Acetic Acid-Modified [d-Glu1]-Minigastrin
Published in Bioconjugate chemistry (01-07-2004)“…Gastrin/CCK-2 receptors are overexpressed in a number of tumors such as medullary thyroid cancer (MTC) and small cell lung cancer (SCLC). Recently…”
Get full text
Journal Article -
16
PP#89 - A proof of concept study with FSC-based hybrid imaging agents for pretargeting applications
Published in Nuclear medicine and biology (01-07-2019)Get full text
Journal Article -
17
PP#166 - 68Ga labelled bacterial siderophore for infection imaging: a proof of principle
Published in Nuclear medicine and biology (01-07-2019)Get full text
Journal Article -
18
PP#167 - 68Ga-labelled, fluorescent siderophores: dual imaging potential in Aspergillus fumigatus infections
Published in Nuclear medicine and biology (01-07-2019)Get full text
Journal Article -
19
[99mTc]Tc-HYNIC-MGS5 and [68Ga]Ga-DOTA-MGS5: two novel imaging probes for cholecystokinin-2 receptor targeting
Published in Nuclear medicine and biology (01-07-2019)Get full text
Journal Article -
20
A proof of concept study with FSC-based hybrid imaging agents for pretargeting applications
Published in Nuclear medicine and biology (01-07-2019)Get full text
Journal Article